Resum

Fern Nichole Alexander, Ph.D. email. ablgxi@r.postjobfree.com

Ph. 530-***-****

Education

Ph.D. Genetics, 1982

University of Pennsylvania

B.A. Biology, 1974

State University of New York at Albany

Additional courses at American Medical Writers Association,

Psychosynthesis Institute, and University of California, Davis

Professional Experience

WordScapes, El Dorado Hills, CA 1988-present

Principal, Healthcare Research, Policy, and Communica-tions Consultant.

Design and conduct outcomes research. Developer of PASHIN, a project to

reform healthcare. Design, research, and write marketing, educational,

and promotional materials for medical societies, research institutes,

publishing firms, and biotechnology/pharmaceutical companies. Write

journal articles, slide presentations, white papers, monographs, online

CME courses, press releases, annual reports, advertising copy, sales

training manuals, and physician newsletters for an international

clientele.

Am. Society Human Genetics, Bethesda, MD 1991-2007

Science Writer. Disseminated information on genetic advances, medical

ethics, and health policy. Organized press programs: selected

topics/speakers for briefings, interviewed physician and scientist

leaders, wrote press releases, and summarized noteworthy presentations.

UC Davis Medical Center, Sacramento, CA 2004-06

Clinical Research Coordinator. Administered, implemented, and

coordinated clinical trials for kidney dialysis patients. Coordinated

patient recruitment and care; served as liaison with FDA, IRB, and drug

company staff ; revised protocols; analyzed data.

Holistic Health Ass'n, Princeton,NJ 1986-1991

Health Consultant. Member, Board of Directors and Program Committee.

Co-chair of a health conference Building Bridges: Our Selves, Our Lives,

Our Planet.

Ctr. Strategic Communications, Morristown, NJ 1989-90

Senior Writer. Prepared healthcare promotional materials.

Bessalaer, Inc. Princeton, NJ 1989

Medical Writer. Prepared FDA documentation.

Waksman Inst., Rutgers Univ., N. Brunswick, NJ 1987-88

Postdoctoral Fellow. Conducted biotechnology research to improve the

nutritional value of corn.

Roche Institute of Molecular Biology at

Hoffmann La Roche, Nutley, NJ 1983-86

Postdoctoral Fellow. Cloned and expressed the reverse transcriptase gene

of an HIV-related virus.

Fox Chase Cancer Institute, Philadelphia, PA 1979-82

Doctoral Candidate. Cloned, sequenced, and analyzed structures of the

genes for serum albumin and alpha-fetoprotein to determine their

evolutionary origins.

Yale School of Medicine, New Haven, CT 1974-77

Research Associate. Organized laboratory to individualize patient

chemotherapy regimens based on in vitro outcomes, and studied anti-

leukemic agents.

Selected Projects

White paper, video, and slide presentation on healthcare reform.

Multimedia physician training program on treatment and management of

patients with asthma.

Bimonthly newsletters on outcomes research for physicians and hospital

administrators.

Compendia categorizing and describing significant discoveries in human

genetics.

Manuscripts published in professional journals on numerous topics

including AIDS, asthma, diabetes, glaucoma, health outcomes, kidney

disease, molecular genetics, oncology, pain management, preterm labor,

quality of life, and rhinitis.

Physician monographs on allergy, obstetrics, oncology, CVD.

Needs assessments in neurology, COPD, urology, CVD.

Annual report for a leading biotechnology company.

Skills/Expertise/Qualifications

Guide the strategic planning, design, and research of projects.

Interview international thought leaders in science and health.

Develop outcomes research protocols.

Work independently, in cooperation with a team, and as liaison.

Interact effectively with healthcare professionals and patients.

Advise on clinical policy and marketing strategy.

Demonstrated skills in leadership and critical thinking.

Areas of expertise: allergy/immunology, chronic conditions (asthma, cancer,

cardiovascular disease, diabetes, kidney disease, and pain management),

genetics and stem cell research, obstetrics and women's health,

prosthetic devices, psychology and mental health, quality of life and

outcomes research.

Honors/Awards/Extra-Curricular

Bd. of Directors, Snowline Hospice, Placerville, CA 2008-present

Bd. of Directors, Art of Living Institute, Marshall

Hospital, Placerville, CA 1994-1996

Award of Excellence, Society for Technical Communications,1994

LuLu Award from Los Angeles Women in Advertising, 1995

Merck Postdoctoral Fellowship Award, 1987-88

Roche Postdoctoral Fellowship Award, 1983-85

U.S. Public Health Service Fellowship Award, 1977-81

Publications

Kymes, SM, Schwartz GF, Fiscella RG, Burk C, Patel VD. The humanistic and

economic burden of glaucoma. Manuscript in preparation.

Developed an innovative, comprehensive patient assessment to monitor the

progress and outcomes of upper limb amputees who receive a

multiarticulating myoelectric prosthetic device and participate in a novel

integrative care research protocol. April, 2010.

Kymes, SM, Schwartz GF, Fiscella RG, Burk C, Patel VD. The humanistic and

economic burden of glaucoma: an update. Poster. World Opthalmology

Conference. Berlin. June, 2010.

Alexander, FN. White Paper: Revitalizing the American Healthcare System.

PASHIN. January, 2010.

Utility elicitation from a sample of able-sighted subjects who underwent a

simulated-glaucoma experience. In preparation.

Don BR, Kim K, Li J, Dwyer T, Alexander F, Kaysen G. The effect of

etanercept on suppression of the systemic inflammatory response in chronic

hemodialysis patients. Clinical Nephrology. 2010; 73:431-438.

Alexander, FN. Videos describing PASHIN and reviewing the demise of the

healthcare system and its effect on healthcare professionals and patients.

PASHIN. 2009.

Endothelin-1 receptor antagonist induced hepatotoxicity in pulmonary

arterial hypertension. In preparation.

Hepatic safety profile of endothelin-1 receptor antagonists: review of

postmarketing data. In preparation.

Alexander, FN. Slide presentation describing the healthcare crisis and its

effect on healthcare professionals and patients. PASHIN. 2008.

Science Writer for the American Society of Human Genetics. Design the

press program and press kits: select topics and speakers for press

briefings with a focus on medical ethics, interview international thought

leaders in science and medicine, prepare compendium and summaries of

conference presentations, and select topics and prepare press releases for

the American Society of Human Genetics. 1991-2007.

Four Needs Assessments to evaluate the need for CME on the topics of:

fibromyalgia, sleep dysfunction and pain, low back pain, and neuropathic

pain. December, 2007.

Briggs DD, Sciurba F, ZuWallack RL. Inactivity and lung function impact

quality of life in patients with COPD. Internal Medicine News. 2007.

Alexander, FN. White Paper. Identification of eight hidden cost

containment strategies for inclusion in healthcare reform. WordScapes.

2007.

Sciurba F, Briggs DD, ZuWallack RL. Inactivity and lung function in

chronic obstructive pulmonary disease. Family Practice News. 2007.

Emerging Solutions in Pain. An Interview with Bill H. McCarberg, MD,

FABPM. What Role Does Age Play in the Management of Chronic Pain in Adult

Patients? A CME-Accredited Monograph. Practical Pain Management. Nov/Dec

2006; 6(8):A-F.

Five Needs Assessments to evaluate the need for CME on the topics of:

benign prostatic hyperplasia, stroke, hypertension, chronic obstructive

pulmonary disease, and chronic pain management. July, 2006-August 2007.

Potter MB. Chronic pain management: practical tips and guidelines for

primary care. Adv Stud Med. 2004; 4:31-40.

Ledford D. Inadequate diagnosis of nonallergic rhinitis: assessing the

damage. Allergy Asthma Proc. 2003; 24:155-162.

Settipane RA. Rhinitis: a dose of epidemiological reality. Allergy Asthma

Proc. 2003; 24:147-154.

Kaliner M. Progressive management strategies in the treatment of rhinitis.

Allergy Asthma Proc. 2003; 24:163-169.

Lieberman PL, Settipane, RA. Azelastine nasal spray: a review of

pharmacology and clinical efficacy in allergic and nonallergic rhinitis.

Allergy Asthma Proc. 2003; 24:95-105.

Rosenwasser LJ. Treatment of allergic rhinitis. Am J Med. 2002;

113(Suppl 9A):17S-24S.

Conti P. The anti-inflammatory actions of azelastine. Allergy Asthma

Proc. 2002; 23:153-155.

Smith J. Computer-assisted diagnostic device broadens scope of MRI. CMRS

Vision. December, 2001.

Online CME presentation on the use of muscle relaxants in acute lower back

pain and myofascial pain. 2001.

Hayden ML. Allergic Rhinitis: A Growing Primary Care Challenge. J Am Acad

Nurse Pract. 2001; 13(12):545-554.

Settipane R. Demographics and Epidemiology of Allergic and Nonallergic

Rhinitis. Allergy Asthma Proc. 2001; 22(4):185-189.

Lieberman P. Treatment Update: Nonallergic Rhinitis. Allergy Asthma

Proc. 2001; 22(4):199-202.

Berger W. Treatment Update: Allergic Rhinitis. Allergy Asthma Proc.

2001; 22(4):191-198.

A commissioned chapter for Philip Lieberman, MD entitled "Topical versus

Oral Antihistamines for Rhinitis" for inclusion in a textbook published by

Current Medicine. 2001.

Berger W. Allergic Rhinitis in Children. Current Allergy and Asthma

Reports. 2001; 1(6):498-505.

Proceedings of the National Allergy Advisory Council meeting on nonallergic

rhinitis held in St. Thomas, US Virgin Islands, October 16, 1999 entitled

"The Broad Spectrum of Rhinitis: Etiology, Diagnosis, and Advances in

Treatment." Wallace Laboratories for publication in Annals of Allergy,

Asthma and Immunology. 2001.

A commissioned article for Philip Lieberman, MD entitled "Relationship

between Rhinitis and Lower Airway Disease." 2000.

Clinician's Manual on Allergic and Nonallergic Rhinitis. Science Press.

2000.

CME article on the importance of accurate differential diagnosis in the

management of rhinitis. Wallace Laboratories. 2000.

Preclinical Evidence of Azelastine Activity. Wallace Laboratories. 2000.

Clinical Review of Azelastine. Wallace Laboratories. 2000.

Heine RP, McGregor JA, Dullien VK. Accuracy of salivary estriol testing

compared to traditional risk factor assessment in predicting preterm birth.

Am J Obstet Gynecol. 1999; 180(1 Pt 3):S214-S218.

Voss, HF. Saliva as a fluid for measurement of estriol levels. Am J

Obstet Gynecol. 1999; 180(1 Pt3):S226-S231.

White Paper comparing Fetal Fibronectin and Salivary Estriol for the

Prediction of Preterm Labor. Biex. 1999.

Slide presentation on nonallergic rhinitis. Wallace Laboratories. 1999.

Hartenbach EM, Harris LS, Bailey HH, et al. Paclitaxel, carboplatin, and

hexamethyl-melamine (taxchex) as first-line therapy for ovarian cancer.

Cancer J Sci Am. Nov-Dec 1999; 5:348-355.

Sales training manual on SalEst, salivary estriol test for predicting

preterm birth. Biex. 1998.

Proceedings of a symposium on SalEst, salivary estriol test for predicting

preterm birth. The Hands of the Placental Clock. Biex. 1998.

Grand Rounds slide presentation on SalEst salivary estriol test for

predicting preterm birth. Biex. 1998.

Slide presentation on the pharmacoeconomics of Neupogen. Amgen. 1997.

SalEst Physician Monograph. Biex. 1997.

Corporate Brochure. Dendreon. 1997.

Product Brochure on the Gene Array Scanner. Hewlett Packard and

Affymetrix. 1997.

Alexander F. Science Writer for the American Society of Human Genetics.

Program Reference Book: Guide for the Press to the annual meeting of the

American Society of Human Genetics. 1994-2000.

Activase Alteplase, for the management of acute ischemic stroke: Summary of

Clinical Data and Product Information. Monograph. Genentech, Inc. 1996.

Outcomes Research Digest. Monthly newsletter. The Zitter Group. December

1994-January 1996.

Outcomes Outlook. Bimonthly newsletter. The Zitter Group.

November/December 1993-September/October 1995.

Kuppermann M, Lubeck DP, Mazonson PD, Patrick DL, Stewart AL, Bueshing DP,

Fifer SK. Sleep problems and their correlates in a working population. J

Gen Intern Med. 1995; 10:25-32.

Annual Report. Amgen, Inc. 1994.

Alexander F. Gene therapy the focus of cystic fibrosis researchers.

Matrix. May 1994; 1(5):6-7.

Mathias SD, Fifer SK, Patrick DL. Rapid translation of quality of life

measures for international clinical trials: avoiding errors in the

minimalist approach. Quality of Life Research. 1994; 3:403-412.

Mathias SD, Fifer SK, Mazonson PD, Lubeck DP, Buesching DP, Patrick DL.

Necessary but not sufficient: the effect of screening and feedback on

outcomes of primary care patients with untreated anxiety. J Gen Intern Med.

1994; 9:606-615.

Stern HS, Maroun JA. Colorectal cancer. Proceedings of a symposium

sponsored by the Canadian Association of General Surgeons and the Canadian

Association of Medical Oncologists, of the Royal College of Physicians and

Surgeons of Canada. Monograph. Princeton: Excerpta Medica. September 16,

1990.

Asthma Education Program. Interactive training for allergists and

pulmonologists on asthma. Sandoz Pharmaceuticals. 1990.

Alexander F, Leis J, Soltis DA, Crowl RM, Danho W, Poonian MS, Pan Y-CE,

Skalka AM. Proteolytic processing of avian sarcoma and leukosis virus pol-

endo recombinant proteins reveals another pol gene domain. J Virol. 1987;

61:534-542.

Alexander F, Soltis D, Crowl R, Leis J, Danho W, Poonian M, Skalka AM.

Synthesis of ALV pol gene products in bacteria: evidence for C-terminal

processing. Abstract presented at RNA Tumor Virus Meeting. Cold Spring

Harbor, NY. 1985. p.134.

Alexander F, Young PR, Tilghman SM. Evolution of the albumin/alpha-

fetoprotein ancestral gene from the amplification of a 27-nucleotide

sequence. J Mol Biol. 1984; 173:159-176.

Alexander Eiferman F, Young PR, Scott RW, Tilghman SM. Intragenic

amplification and divergence in the mouse alpha-fetoprotein gene. Nature.

1981; 294:713-718.

Kioussis D, Eiferman* F, van de Rijn P, Gorin MB, Ingram RS, Tilghman SM.

The evolution of alpha-fetoprotein and albumin. II. The structures of the

alpha-fetoprotein and albumin genes in the mouse. J Biol Chem. 1981;

256:1960-1967.

Gorin MB, Cooper DL, Eiferman* F, van de Rijn P, Tilghman SM. The

evolution of alpha-fetoprotein and albumin. I. A comparison of the primary

amino acid sequences of a mammalian alpha-fetoprotein and albumin. J Biol

Chem. 1981; 256:1954-1959.

Tilghman SM, Gorin MB, Kioussis D, Eiferman* F, van de Rijn P, Ingram RS.

The structures of the alpha-fetoprotein and albumin genes in the mouse. in

Proceedings of the 2nd International Symposium of RNA in Development and

Reproduction. Niu MC and Chuang HH, eds. Science Press. 1981. pp 772-

786.

Cadman E, Eiferman* F. Mechanism of synergistic cell killing when

methotrexate precedes cytosine arabinoside. J Clin Invest. 1979; 64:788.

Cadman E, Eiferman* F, Heimer R, Davis L. Pyrazofurin enhancement of 5-

azacytidine antitumor activity in L5178Y and human leukemia cells. Cancer

Res. 1978; 38:4610-4617.

*aka Fern Alexander Eiferman

Contact this candidate